escitalopram has been researched along with ADDH in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalsa, SS; Kuplicki, R; Paulus, MP; Victor, TA; Yeh, HW | 1 |
| Alhambra, DP; Kim, C; Kim, SJ; Lee, DY; Lee, J; Lee, S; Lee, YH; Park, J; Park, RW; Shin, Y; Tan, EH; Yang, SJ | 1 |
1 trial(s) available for escitalopram and ADDH
| Article | Year |
|---|---|
Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Central Nervous System Stimulants; Double-Blind Method; Escitalopram; Humans; Methylphenidate; Pilot Projects; Treatment Outcome | 2021 |
1 other study(ies) available for escitalopram and ADDH
| Article | Year |
|---|---|
Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression:
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Depression; Escitalopram; Fluoxetine; Humans; Methylphenidate; Selective Serotonin Reuptake Inhibitors; Tic Disorders | 2023 |